BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

912 related articles for article (PubMed ID: 21415165)

  • 1. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
    Ward C; Meehan J; Mullen P; Supuran C; Dixon JM; Thomas JS; Winum JY; Lambin P; Dubois L; Pavathaneni NK; Jarman EJ; Renshaw L; Um IH; Kay C; Harrison DJ; Kunkler IH; Langdon SP
    Oncotarget; 2015 Sep; 6(28):24856-70. PubMed ID: 26259239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
    Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
    Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion.
    Robertson N; Potter C; Harris AL
    Cancer Res; 2004 Sep; 64(17):6160-5. PubMed ID: 15342400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.
    Ellingsen C; Andersen LM; Galappathi K; Rofstad EK
    BMC Cancer; 2015 Oct; 15():805. PubMed ID: 26502718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells.
    Zandberga E; Zayakin P; Ābols A; Pūpola D; Trapencieris P; Linē A
    Cancer Biol Ther; 2017 Aug; 18(8):596-605. PubMed ID: 28665755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells.
    Ivanova L; Zandberga E; Siliņa K; Kalniņa Z; Ābols A; Endzeliņš E; Vendina I; Romanchikova N; Hegmane A; Trapencieris P; Eglītis J; Linē A
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):235-46. PubMed ID: 25422154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production.
    Chafe SC; Lou Y; Sceneay J; Vallejo M; Hamilton MJ; McDonald PC; Bennewith KL; Möller A; Dedhar S
    Cancer Res; 2015 Mar; 75(6):996-1008. PubMed ID: 25623234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Sulfamate Small Molecule CAIX Inhibitor S4 Modulates Doxorubicin Efficacy.
    van Kuijk SJ; Gieling RG; Niemans R; Lieuwes NG; Biemans R; Telfer BA; Haenen GR; Yaromina A; Lambin P; Dubois LJ; Williams KJ
    PLoS One; 2016; 11(8):e0161040. PubMed ID: 27513947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and activity of carbonic anhydrase IX is associated with metabolic dysfunction in MDA-MB-231 breast cancer cells.
    Li Y; Wang H; Oosterwijk E; Tu C; Shiverick KT; Silverman DN; Frost SC
    Cancer Invest; 2009 Jul; 27(6):613-23. PubMed ID: 19367501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH.
    Chiche J; Ilc K; Laferrière J; Trottier E; Dayan F; Mazure NM; Brahimi-Horn MC; Pouysségur J
    Cancer Res; 2009 Jan; 69(1):358-68. PubMed ID: 19118021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs.
    Dubois L; Peeters SG; van Kuijk SJ; Yaromina A; Lieuwes NG; Saraya R; Biemans R; Rami M; Parvathaneni NK; Vullo D; Vooijs M; Supuran CT; Winum JY; Lambin P
    Radiother Oncol; 2013 Sep; 108(3):523-8. PubMed ID: 23849171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting carbonic anhydrase IX with small organic ligands.
    Wichert M; Krall N
    Curr Opin Chem Biol; 2015 Jun; 26():48-54. PubMed ID: 25721398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX Expression.
    Stengel C; Newman SP; Leese MP; Thomas MP; Potter BV; Reed MJ; Purohit A; Foster PA
    Anticancer Res; 2015 Oct; 35(10):5249-61. PubMed ID: 26408684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
    Carradori S
    Expert Opin Ther Pat; 2013; 23(6):751-6. PubMed ID: 23387899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing carbonic anhydrase inhibitors for the treatment of breast cancer.
    Supuran CT; Winum JY
    Expert Opin Drug Discov; 2015 Jun; 10(6):591-7. PubMed ID: 25891195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers.
    Marks IS; Gardeen SS; Kurdziel SJ; Nicolaou ST; Woods JE; Kularatne SA; Low PS
    Mol Pharm; 2018 Jun; 15(6):2289-2296. PubMed ID: 29715036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.
    Touisni N; Maresca A; McDonald PC; Lou Y; Scozzafava A; Dedhar S; Winum JY; Supuran CT
    J Med Chem; 2011 Dec; 54(24):8271-7. PubMed ID: 22077347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast.
    van Brussel AS; Adams A; Vermeulen JF; Oliveira S; van der Wall E; Mali WP; van Diest PJ; van Bergen En Henegouwen PM
    Breast Cancer Res Treat; 2013 Jul; 140(2):263-72. PubMed ID: 23860929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.